Several randomized trials with metabolic outcomes have reported that glucagon like peptide-1 receptor agonists (GLP-1 RA) could be associated with an increased risk of pancreatitis. The present meta-analysis aimed to examine this hypothesis.
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials / Monami, Matteo; Dicembrini, Ilaria; Nardini, Camilla; Fiordelli, Irene; Mannucci, Edoardo. - In: DIABETES RESEARCH AND CLINICAL PRACTICE. - ISSN 0168-8227. - STAMPA. - 103:(2014), pp. 269-275. [10.1016/j.diabres.2014.01.010]
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials
DICEMBRINI, ILARIA;MANNUCCI, EDOARDO
2014
Abstract
Several randomized trials with metabolic outcomes have reported that glucagon like peptide-1 receptor agonists (GLP-1 RA) could be associated with an increased risk of pancreatitis. The present meta-analysis aimed to examine this hypothesis.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
